Cargando…
Glycoconjugate vaccines: classic and novel approaches
Glycoconjugate vaccines, obtained by carbohydrates covalently bound to protein carriers, have contributed to fight diseases such as meningitidis, pneumonia and typhoid fever. Despite new technologies such as RNA and adenovirus based vaccine have now reached the market, these approaches are unable to...
Autor principal: | Adamo, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225458/ https://www.ncbi.nlm.nih.gov/pubmed/34169357 http://dx.doi.org/10.1007/s10719-021-09997-5 |
Ejemplares similares
-
Editorial: Glycoconjugates in vaccines and immunotherapeutics
por: Shivatare, Sachin, et al.
Publicado: (2022) -
Potential targets for next generation antimicrobial glycoconjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2018) -
Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
por: Morais, Victor, et al.
Publicado: (2022) -
Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends
por: Micoli, Francesca, et al.
Publicado: (2018) -
Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human
por: Barel, Louis-Antoine, et al.
Publicado: (2019)